Panacea Biotec, a company in the Pharmaceuticals industry, reported revenue of ₹190 crore and net profit of ₹12 crore for the September 2026 quarter.
Panacea Biotec (NSE: PANACEABIO) closed at ₹335.95 on 20 Nov 2026, down 5.8% over the past year. Its market capitalisation is ₹2,058 crore and it trades at 190.4 times earnings.
Incorporated in 1984, Panacea Biotec Ltd is a research-based biotechnology company
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.